Halofantrine clinical pharmacology

Revision as of 02:44, 7 January 2014 by Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Halofantrine}} {{CMG}} <ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20250s7s8lbl.pdf | url =http:/...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Halofantrine
HALFAN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]



[1]

References

  1. ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20250s7s8lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Halofantrine_clinical_pharmacology&oldid=926977"